Post-Marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Syrup Among Filipino Pediatric Patients.
Phase of Trial: Phase III
Latest Information Update: 02 Oct 2014
At a glance
- Drugs Desloratadine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Adverse reactions
- Sponsors Merck & Co; Merck Sharp & Dohme; Schering-Plough
- 27 Jan 2012 Trial phase changed from II to III as reported by ClinicalTrials.gov.
- 27 Jan 2012 Actual patient number (2980) added as reported by ClinicalTrials.gov.
- 22 Sep 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.